- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 2.94M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 2.9M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 2.82M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$221.98K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$432.55K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $23.97K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$7.02M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$5.76M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$4.14M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$3.13M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $8.2M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $7.01M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $8.65M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $7.46M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.54M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.55M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.63M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.7M |
| Total Assets | Q1 2026 · Mar 31, 2025 | $2.06M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.56 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.37 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.56 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.37 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $847.28K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $629.42K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.62M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.05M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$700.81K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$617.39K |